HRS/ACCF expert consensus statement on pacemaker device and mode selection

Journal of the American College of Cardiology

Volumn 60, Issue 7, 2012, Pages 682-703

  Gillis, Anne M ^a   Russo, Andrea M ^b   Ellenbogen, Kenneth A ^c   Swerdlow, Charles D ^d   Olshansky, Brian ^e   Al Khatib, Sana M ^f   Beshai, John F ^g   McComb, Janet M ^h   Nielsen, Jens Cosedis ⁱ   Philpott, Jonathan M ^j   Shen, Win Kuang ^k  

^a UNIVERSITY OF CALGARY   (Canada)

^b Cooper University Hospital ^*  (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^h FREEMAN HOSPITAL   (United Kingdom)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j Mayo Clinic College of Medicine ^*

^k Mayo Clinic   (United States)

more..

Author keywords

ACCF Expert Consensus Document; AV block; pacemaker mode; sinus node disease

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; CAROTID SINUS SYNDROME; CATHETER ABLATION; CLINICAL DECISION MAKING; COMPLETE HEART BLOCK; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DUAL CHAMBER VENTRICLE PACING; EXERCISE; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FAILURE; HEART RHYTHM SOCIETY; HEART VENTRICLE PACING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MORTALITY; PACEMAKER FAILURE; PACEMAKER SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SINGLE CHAMBER VENTRICLE PACING; SINUS NODE DYSFUNCTION; STROKE; SYNCOPE; THROMBOEMBOLISM;

ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; COST-BENEFIT ANALYSIS; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 84864714818     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.06.011     Document Type: Article

References (133)

1. A.E. Epstein ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
2. M. Jessup 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults J Am Coll Cardiol 53 2009 1343 1382
3. K. Dickstein 2010 focused update of ESC guidelines on device therapy in heart failure Europace 12 2010 1526 1536
4. ACCF/AHA Task Force on Practice Guidelines Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines acc.org.2009 http://assets.cardiosource.com/Methodology-Manual-for-ACC-AHA-Writing- Committees.pdf Accessed June 2012
5. G.A. Lamas Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing N Engl J Med 338 1998 1097 1104
6. S.J. Connolly Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes Canadian Trial of Physiologic Pacing Investigators N Engl J Med 342 2000 1385 1391
7. C.R. Kerr Canadian Trial of Physiological Pacing: effects of physiological pacing during long-term follow-up Circulation 109 2004 357 362
8. G.A. Lamas Ventricular pacing or dual-chamber pacing for sinus-node dysfunction N Engl J Med 346 2002 1854 1862
9. J.S. Healey Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data Circulation 114 2006 11 17
10. J.C. Nielsen A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome Eur Heart J 32 2011 686 696
11. L. Padeletti Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSISLOG study Pacing Clin Electrophysiol 29 2006 34 40
12. G.A. Lamas Impact of rate-modulated pacing on quality of life and exercise capacity - evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT) Heart Rhythm 4 2007 1125 1132
13. M.O. Sweeney Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease N Engl J Med 357 2007 1000 1008
14. H.R. Andersen Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome Lancet 350 1997 1210 1216
15. H.R. Andersen Atrioventricular conduction during long-term follow-up of patients with sick sinus syndrome Circulation 98 1998 1315 1321
16. L. Kristensen AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker Pacing Clin Electrophysiol 24 2001 358 365
17. A.M. Gillis Pacing for sinus node disease: diagnosis, pathophysiology and prognosis K. Ellenbogen, Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy 2011 Elsevier Philadelphia 300 322
18. A.M. Gillis Redefining physiologic pacing: lessons learned from recent clinical trials Heart Rhythm 3 2006 1367 1372
19. R. Sutton, T.A. Kenny The natural history of sick sinus syndrome Pacing Clin Electrophysiol 9 6 Pt 2 1986 1110 1114
20. J. Brandt Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode J Am Coll Cardiol 20 1992 633 639
21. A.M. Gillis, M. Morck Atrial fibrillation after DDDR pacemaker implantation J Cardiovasc Electrophysiol 13 2002 542 547
22. W.D. Toff, A.J. Camm, J.D. Skehan Single-chamber versus dual-chamber pacing for high-grade atrioventricular block N Engl J Med 353 2005 145 155
23. J.S. Healey Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
24. T.V. Glotzer The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
25. V. Fuster 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 57 2011 e101 e198
26. D. Newman Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing Am Heart J 145 2003 430 437
27. K.E. Fleischmann Pacemaker implantation and quality of life in the Mode Selection Trial (MOST) Heart Rhythm 3 2006 653 659
28. A.S. Tang Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes Circulation 103 2001 3081 3085
29. A. Baranchuk The effect of atrial-based pacing on exercise capacity as measured by the 6-minute walk test: a substudy of the Canadian Trial of Physiological Pacing (CTOPP) Heart Rhythm 4 2007 1024 1028
30. K.A. Ellenbogen The pacemaker syndrome - a matter of definition Am J Cardiol 79 1997 1226 1229
31. D. Heldman True incidence of pacemaker syndrome Pacing Clin Electrophysiol 13 12 Pt 2 1990 1742 1750
32. K.A. Ellenbogen Clinical characteristics of patients intolerant to VVIR pacing Am J Cardiol 86 2000 59 63
33. M.S. Link High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST) J Am Coll Cardiol 43 2004 2066 2071
34. J. Dretzke Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block Cochrane Database Syst Rev 2004 CD003710
35. S. Furman Pacemaker syndrome Pacing Clin Electrophysiol 17 1994 1 5
36. K. Ausubel, S. Furman The pacemaker syndrome Ann Intern Med 103 1985 420 429
37. M.O. Sweeney Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction Circulation 107 2003 2932 2937
38. B.L. Wilkoff Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial JAMA 288 2002 3115 3123
39. R. Willems Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy J Cardiovasc Electrophysiol 14 2003 1296 1301
40. A. Barsheshet Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator Heart Rhythm 8 2011 212 218
41. A.M. Gillis High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation Heart Rhythm 2 2005 791 796
42. L.F. Tops, M.J. Schalij, J.J. Bax The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy J Am Coll Cardiol 54 2009 764 776
43. A.E. Albertsen DDD(R)-pacing, but not AAI(R)-pacing induces left ventricular desynchronization in patients with sick sinus syndrome: tissue-Doppler and 3D echocardiographic evaluation in a randomized controlled comparison Europace 10 2008 127 133
44. J.C. Nielsen Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing Circulation 97 1998 987 995
45. A.D. Sharma Percent right ventricular pacing predicts outcomes in the DAVID trial Heart Rhythm 2 2005 830 834
46. J.S. Steinberg The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II J Cardiovasc Electrophysiol 16 2005 359 365
47. M.D. Smit Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients Heart Rhythm 3 2006 1397 1403
48. R.A. Veasey The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study Europace 3 2011 815 820
49. A.M. Gillis Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block Pacing Clin Electrophysiol 29 2006 697 705
50. M. Steinbach Outcome of patients aged over 75 years who received a pacemaker to treat sinus node dysfunction Arch Cardiovasc Dis 104 2011 89 96
51. J.C. Nielsen Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing Europace 14 2012 682 689
52. S. Cheng Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block JAMA 301 2009 2571 2577
53. L.U. Elkayam The influence of atrial and ventricular pacing on the incidence of atrial fibrillation: a meta-analysis Pacing Clin Electrophysiol 4 2011 1593 1599
54. B. Olshansky Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study Circulation 115 2007 9 16
55. M.O. Sweeney Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? J Am Coll Cardiol 50 2007 614 622
56. C. Vavasis Frequent recurrent polymorphic ventricular tachycardia during sleep due to managed ventricular pacing Pacing Clin Electrophysiol 33 2010 641 644
57. R. van Mechelen, R. Schoonderwoerd Risk of managed ventricular pacing in a patient with heart block Heart Rhythm 3 2006 1384 1385
58. I. Kruse A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing Circulation 65 1982 846 855
59. B. Nowak Cardiac output in single-lead VDD pacing versus rate-matched VVIR pacing Am J Cardiol 75 1995 904 907
60. B. Hunt, A.M. Gillis Natural history of MVP mode in a single centre cohort Can J Cardiol 27 2011 S264 S265
61. K.A. Ellenbogen, M.A. Wood, B.S. Stambler Pacemaker syndrome: clinical, hemodynamic, and neurohormonal features S.S. Barold, J. Mugica, New Perspectives in Cardiac Pacing 1994 Futura Publishing Co Mt Kisco, NY 85 112
62. S.A. Kontoyannis, J.N. Nanas, S.F. Stamatelopoulos Congestive heart failure treated by the upgrade from VVI to DDD pacing Acta Cardiol 55 2000 41 43
63. R.A. Nishimura Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study J Am Coll Cardiol 25 1995 281 288
64. K.A. Ellenbogen, M.D. Thames, P.K. Mohanty New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing Am J Cardiol 65 1990 53 59
65. A.C. Skanes Canadian Trial of Physiologic Pacing Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing. CTOPP Investigators J Am Coll Cardiol 38 2001 167 172
66. D.P. Lipkin The role of exercise testing in chronic heart failure Br Heart J 58 1987 559 566
67. N. Sulke A randomized double-blind crossover comparison of four rate-responsive pacing modes J Am Coll Cardiol 17 1991 696 706
68. K. Kamalvand Is mode switching beneficial? A randomized study in patients with paroxysmal atrial tachyarrhythmias J Am Coll Cardiol 30 1997 496 504
69. P. Avery Physiological pacing improves symptoms and increases exercise capacity in the elderly patient Int J Cardiol 46 1994 129 133
70. K.M. Channon DDD vs. VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison QJM 87 1994 245 251
71. J.-C. Deharo A randomized, single-blind crossover comparison of the effects of chronic DDD and dual sensor VVIR pacing mode on quality-of- life and cardiopulmonary performance in complete heart block Pacing Clin Electrophysiol 19 1996 1320 1326
72. M.R. Hargreaves Comparison of dual chamber and ventricular rate responsive pacing in patients over 75 with complete heart block Br Heart J 74 1995 397 402
73. K.G. Oldroyd Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block Br Heart J 65 1991 188 193
74. E. Castelnuovo The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation Health Technol Assess 9 2005 1 246 iii, xi-xiii
75. E.J. Perrins Randomised controlled trial of physiological and ventricular pacing Br Heart J 50 1983 112 117
76. N.A. Boon A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing Br Heart J 58 1987 34 39
77. C. Linde-Edelstam Longevity in patients with high degree atrioventricular block paced in the atrial synchronous or the fixed rate ventricular inhibited mode Pacing Clin Electrophysiol 15 1992 304 313
78. N. Sulke "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices Br Heart J 67 1992 57 64
79. C.-P. Lau Quality-of-life in DDDR pacing: atrioventricular synchrony or rate adaptation? Pacing Clin Electrophysiol 17 1994 1838 1843
80. J. Lukl, V. Doupal, P. Heinc Quality-of-life during DDD and dual sensor VVIR pacing Pacing Clin Electrophysiol 17 1994 1844 1848
81. S. Ouali DDD versus VVIR pacing in patients, ages 70 and over, with complete heart block Pacing Clin Electrophysiol 33 2010 583 589
82. C.J. Höijer Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation Eur Heart J 23 2002 490 497
83. G.M. Gribbin Individualised quality of life after pacing Does mode matter? Europace 6 2004 552 560
84. G.M. Gribbin The effect of pacemaker mode on cognitive function Heart 91 2005 1209 1210
85. M.A. Wood Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis Circulation 101 2000 1138 1144
86. L. Gianfranchi Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias Am J Cardiol 81 1998 351 354
87. H.J. Marshall Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm Circulation 99 1999 1587 1592
88. A.M. Gillis Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation The Atrial Pacing Peri-Ablation for Paroxysmal Atrial Fibrillation (PA(3)) Study Investigators Circulation 102 2000 736 741
89. J.M. McComb, G.M. Gribbin Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: determinants and treatment Europace 1 1999 30 34
90. M. Brignole An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation Eur Heart J 23 2002 892 900
91. M.O. Sweeney Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs J Cardiovasc Electrophysiol 16 2005 811 817
92. B. Olshansky Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators Heart Rhythm 4 2007 886 891
93. G. Milasinovic Percent ventricular pacing with managed ventricular pacing mode in standard pacemaker population Europace 10 2008 151 155
94. H.G. Mond The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001 Pacing Clin Electrophysiol 27 2004 955 964
95. B.A. Schaer Value of VDD-pacing systems in patients with atrioventricular block: experience over a decade Int J Cardiol 122 2007 239 243
96. I. Zupan Retrospective analysis of mode survival, reliability of atrial sensing and incidence of atrial tachyarrhythmias in 307 single-lead VDD pacemaker patients Europace 8 2006 855 858
97. J.A. Taylor Higher sympathetic nerve activity during ventricular (VVI) than during dual-chamber (DDD) pacing J Am Coll Cardiol 28 1996 1753 1758
98. A.M. Gillis, C.R. Kerr Whither physiologic pacing? Implications of CTOPP Pacing Clin Electrophysiol 23 2000 1193 1196
99. B. Naegeli Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing Europace 9 2007 194 199
100. C. Leclercq Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing Am Heart J 129 1995 1133 1141
101. M.R. Gold Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 85 2000 1106 1109
102. C.A. Morley Carotid sinus syncope treated by pacing Analysis of persistent symptoms and role of atrioventricular sequential pacing Br Heart J 47 1982 411 418
103. D.I. Peretz, A. Abdulla Management of cardioinhibitory hypersensitive carotid sinus syncope with permanent cardiac pacing - a seventeen year prospective study Can J Cardiol 1 1985 86 91
104. M. Brignole Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome Am J Cardiol 69 1992 1039 1043
105. M. Brignole Ventricular and dual chamber pacing for treatment of carotid sinus syndrome Pacing Clin Electrophysiol 12 4 Pt 1 1989 582 590
106. S.J. McIntosh A study comparing VVI and DDI pacing in elderly patients with carotid sinus syndrome Heart 77 1997 553 557
107. C.J. McLeod, J.M. Trusty, S.M. Jenkins, R.F. Rea, Y.-M. Cha, R.A. Espinosa, P.A. Friedman, D.L. Hayes, W.-K. Shen Method of pacing does not affect the recurrence of syncope in carotid sinus syndrome Pacing Clin Electrophysiol 2012 10.1111/j.1540-8159.2012.03375.x [E-pub ahead of print]
108. J.S. Sra Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole N Engl J Med 328 1993 1085 1090
109. R. Sheldon, S. Connolly Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials Card Electrophysiol Rev 7 2003 411 415
110. S.J. Connolly Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial JAMA 289 2003 2224 2229
111. S.J. Connolly The North American Vasovagal Pacemaker Study (VPS) A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope J Am Coll Cardiol 33 1999 16 20
112. S. Sud The expectation effect and cardiac pacing for refractory vasovagal syncope Am J Med 120 2007 54 62
113. D.G. Benditt Cardiac pacing for prevention of recurrent vasovagal syncope Ann Intern Med 122 1995 204 209
114. A. Raviele A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope The vasovagal syncope and pacing trial (SYNPACE) Eur Heart J 25 2004 1741 1748
115. M. Brignole International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design Europace 9 2007 25 30
116. M. Brignole Analysis of rhythm variation during spontaneous cardioinhibitory neurally-mediated syncope Implications for RDR pacing optimization: an ISSUE 2 substudy Europace 9 2007 305 311
117. M. Eldar Permanent cardiac pacing in patients with the long QT syndrome J Am Coll Cardiol 10 1987 600 607
118. A.J. Moss Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome Circulation 84 1991 1524 1529
119. M. Eldar Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome J Am Coll Cardiol 20 1992 830 837
120. A.J. Fuenmayor, M.E. Delgado Ventricular repolarization during uni and biventricular pacing in normal subjects Int J Cardiol 2011; Aug 17 10.1016/j.ijcard.2011.07.075 [E-pub ahead of print]
121. L. Fananapazir Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy Circulation 85 1992 2149 2161
122. L. Fananapazir Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy Circulation 90 1994 2731 2742
123. L. Kappenberger et al. Pacing in hypertrophic obstructive cardiomyopathy A randomized crossover study. PIC Study Group Eur Heart J 18 1997 1249 1256
124. B.J. Maron Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy A randomized, double-blind, crossover study (M-PATHY) Circulation 99 1999 2927 2933
125. R.A. Nishimura Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial J Am Coll Cardiol 29 1997 435 441
126. D.J. Hildick-Smith Ventricular pacemaker upgrade: experience, complications and recommendations Heart 79 1998 383 387
127. J.E. Poole Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry Circulation 122 2010 1553 1561
128. S. Rinfret Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction Circulation 111 2005 165 172
129. B.J. O'Brien Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic Pacing Heart Rhythm 2 2005 270 275
130. H.B. Deniz Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy J Cardiovasc Med (Hagerstown) 9 2008 43 50
131. J. Caro, A. Ward, J. Moller Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK Europace 8 2006 449 455
132. G.H. Guyatt Going from evidence to recommendations BMJ 336 2008 1049 1051
133. G.H. Guyatt GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 996